Patient characteristics, Adherence, and Clinical Outcomes among People Living with HIV (PLWH), Initiating Cabotegravir + Rilpivirine LA Regimen in the OPERA Cohort

First published 04/01/2025

Last updated 03/07/2025

EU PAS number:

EUPAS1000000427

Study

Ongoing

Documents

Study protocol

Updated protocol

OPERA_CAB+RPV LA Usage and Clinical Outcomes_Protocol Amendment 3 Anonymised 26 Jun 2025.pdf

First published: 02/07/2025

English (823.44 KB - PDF) View document

OPERA_CABENUVA Usage and Clinical Outcomes_Protocol Amendment 1 Anonymised 15 Oct 2024.pdf

First published: 20/12/2024

English (688.62 KB - PDF) View document

Study results

Study report

Other information

Secondary tabs